Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Intravenous Solutions Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Intravenous Solutions Market Status and Forecast (2016-2027)
      • 1.3.2 Global Intravenous Solutions Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Intravenous Solutions Supply by Company

    • 2.1 Global Intravenous Solutions Sales Volume by Company
    • 2.2 Global Intravenous Solutions Sales Value by Company
    • 2.3 Global Intravenous Solutions Price by Company
    • 2.4 Intravenous Solutions Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Intravenous Solutions Market Status by Category

    • 3.1 Intravenous Solutions Category Introduction
      • 3.1.1 Crystalloids
      • 3.1.2 Colloids
      • 3.1.3 Others
    • 3.2 Global Intravenous Solutions Market by Category
      • 3.2.1 Global Intravenous Solutions Sales Volume by Category (2016-2021)
      • 3.2.2 Global Intravenous Solutions Sales Value by Category (2016-2021)
      • 3.2.3 Global Intravenous Solutions Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Intravenous Solutions Market Status by End User/Segment

    • 4.1 Intravenous Solutions Segment by End User/Segment
      • 4.1.1 Basic IV Solutions
      • 4.1.2 Nutrient Infusion Solution
      • 4.1.3 Others
    • 4.2 Global Intravenous Solutions Market by End User/Segment
      • 4.2.1 Global Intravenous Solutions Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Intravenous Solutions Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Intravenous Solutions Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Intravenous Solutions Market Status by Region

    • 5.1 Global Intravenous Solutions Market by Region
      • 5.1.1 Global Intravenous Solutions Sales Volume by Region
      • 5.1.2 Global Intravenous Solutions Sales Value by Region
    • 5.2 North America Intravenous Solutions Market Status
    • 5.3 Europe Intravenous Solutions Market Status
    • 5.4 Asia Pacific Intravenous Solutions Market Status
    • 5.5 Central & South America Intravenous Solutions Market Status
    • 5.6 Middle East & Africa Intravenous Solutions Market Status

    6 North America Intravenous Solutions Market Status

    • 6.1 North America Intravenous Solutions Market by Country
      • 6.1.1 North America Intravenous Solutions Sales Volume by Country (2016-2021)
      • 6.1.2 North America Intravenous Solutions Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Intravenous Solutions Market Status

    • 7.1 Europe Intravenous Solutions Market by Country
      • 7.1.1 Europe Intravenous Solutions Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Intravenous Solutions Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Intravenous Solutions Market Status

    • 8.1 Asia Pacific Intravenous Solutions Market by Country
      • 8.1.1 Asia Pacific Intravenous Solutions Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Intravenous Solutions Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Intravenous Solutions Market Status

    • 9.1 Central & South America Intravenous Solutions Market by Country
      • 9.1.1 Central & South America Intravenous Solutions Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Intravenous Solutions Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Intravenous Solutions Market Status

    • 10.1 Middle East & Africa Intravenous Solutions Market by Country
      • 10.1.1 Middle East & Africa Intravenous Solutions Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Intravenous Solutions Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Intravenous Solutions Distributors
    • 11.3 Intravenous Solutions Buyers

    12 Global Intravenous Solutions Market Forecast by Category and by End User/Segment

    • 12.1 Global Intravenous Solutions Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Intravenous Solutions Forecast by Category
      • 12.2.1 Global Intravenous Solutions Sales Volume Forecast by Category
      • 12.2.2 Global Intravenous Solutions Sales Value Forecast by Category
      • 12.2.3 Global Intravenous Solutions Price Forecast by Category
    • 12.3 Global Intravenous Solutions Forecast by End User/Segment
      • 12.3.1 Global Intravenous Solutions Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Intravenous Solutions Sales Value Forecast by End User/Segment
      • 12.3.3 Global Intravenous Solutions Price Forecast by End User/Segment

    13 Global Intravenous Solutions Market Forecast by Region/Country

    • 13.1 Global Intravenous Solutions Market Forecast by Region (2022-2027)
      • 13.1.1 Global Intravenous Solutions Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Intravenous Solutions Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Baxter
      • 14.1.1 Company Information
      • 14.1.2 Intravenous Solutions Product Introduction
      • 14.1.3 Baxter Intravenous Solutions Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 Hospira
      • 14.2.1 Company Information
      • 14.2.2 Intravenous Solutions Product Introduction
      • 14.2.3 Hospira Intravenous Solutions Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 B. Braun Melsungen
      • 14.3.1 Company Information
      • 14.3.2 Intravenous Solutions Product Introduction
      • 14.3.3 B. Braun Melsungen Intravenous Solutions Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Fresenius Kabi
      • 14.4.1 Company Information
      • 14.4.2 Intravenous Solutions Product Introduction
      • 14.4.3 Fresenius Kabi Intravenous Solutions Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 Claris Lifesciences
      • 14.5.1 Company Information
      • 14.5.2 Intravenous Solutions Product Introduction
      • 14.5.3 Claris Lifesciences Intravenous Solutions Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 Grifols
      • 14.6.1 Company Information
      • 14.6.2 Intravenous Solutions Product Introduction
      • 14.6.3 Grifols Intravenous Solutions Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 Vifor Pharma
      • 14.7.1 Company Information
      • 14.7.2 Intravenous Solutions Product Introduction
      • 14.7.3 Vifor Pharma Intravenous Solutions Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 JW Life Science
      • 14.8.1 Company Information
      • 14.8.2 Intravenous Solutions Product Introduction
      • 14.8.3 JW Life Science Intravenous Solutions Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Intravenous Solutions market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Intravenous Solutions market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Crystalloids
    Colloids
    Others

    Segmented by End User/Segment
    Basic IV Solutions
    Nutrient Infusion Solution
    Others

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    Baxter
    Hospira
    B. Braun Melsungen
    Fresenius Kabi
    Claris Lifesciences
    Grifols
    Vifor Pharma
    JW Life Science
    Buy now